Can multimodality molecular imaging detect key cellular events in early aortic valve disease in vivo?
Multimodality molecular imaging is capable of identifying early pathological cellular activities in aortic valve disease in vivo.
Molecular imaging can detect in vivo the key cellular events in early aortic valve disease, including endothelial cell and macrophage activation, proteolytic activity, and osteogenesis.
Aïkawa et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: